J. Lipid Res. Acyl Labeled PIP's available August 1, 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lindsey, S.
Right arrow Articles by Hayes, K. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lindsey, S.
Right arrow Articles by Hayes, K. C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol 33, 647-658, Copyright © 1992 by Lipid Research, Inc.


ARTICLES

Low density lipoprotein from humans supplemented with n-3 fatty acids depresses both LDL receptor activity and LDLr mRNA abundance in HepG2 cells

S Lindsey, A Pronczuk and KC Hayes
Foster Biomedical Research Laboratory, Brandeis University, Waltham, MA 02254.

Fish oil supplementation in humans is often associated with an expanded low density lipoprotein (LDL) pool that is not thought to reflect increased production. Since data on clearance of LDL after fish oil supplementation (FO-LDL) are equivocal, normal volunteers (four men and three women) received ten capsules containing 3.6 g eicosapentaenoic acid and 2.9 g docosahexaenoic acid (approximately 2.5% total calories as methyl esters) for 2 weeks. Total plasma cholesterol was unchanged, but triglycerides decreased 30%. Low density lipoprotein cholesterol (LDL-C) and high density lipoprotein cholesterol (HDL-C) were unchanged. Analysis of the LDL particles revealed that increased esterified cholesterol caused the FO-LDL core/surface ratio to be greater than baseline LDL (BL-LDL), resulting in a shift in mean LDL density from 1.060 to 1.056. N-3 fatty acids in FO-LDL were also increased greater than 40% at the expense of n-6 and n-9 fatty acids. Human hepatoma HepG2 cells were used to study the effects of FO-LDL on LDL receptor activity and mRNA abundance for the LDL receptor, 3- hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, and various apolipoproteins associated with cholesterol metabolism. In this system FO-LDL reduced LDL receptor activity compared to BL-LDL. Scatchard analysis revealed that LDL receptor number (Bmax) was reduced to one- third normal (P less than 0.001) whereas particle binding affinity was unchanged. The mRNA abundance for the LDL receptor and apoA-I were also depressed, even by low concentrations (10 micrograms/ml and 20 micrograms/ml LDL protein) of FO-LDL as compared to BL-LDL. HepG2 cells incubated with FO-LDL had decreased cellular free cholesterol but increased cholesteryl esters. Thus, moderate supplementation with fish oil n-3 fatty acids in normal humans enriches their LDL particles in cholesteryl esters and n-3 fatty acids. These particles depress both LDL receptor activity and LDL receptor mRNA abundance in HepG2 cells.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
K. G. Jackson, V. Maitin, D. S. Leake, P. Yaqoob, and C. M. Williams
Saturated fat-induced changes in Sf 60-400 particle composition reduces uptake of LDL by HepG2 cells
J. Lipid Res., February 1, 2006; 47(2): 393 - 403.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. Yu-Poth, D. Yin, P. M. Kris-Etherton, G. Zhao, and T. D. Etherton
Long-Chain Polyunsaturated Fatty Acids Upregulate LDL Receptor Protein Expression in Fibroblasts and HepG2 Cells
J. Nutr., November 1, 2005; 135(11): 2541 - 2545.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
Z. Li, S. Lamon-Fava, J. Otvos, A. H. Lichtenstein, W. Velez-Carrasco, J. R. McNamara, J. M. Ordovas, and E. J. Schaefer
Fish Consumption Shifts Lipoprotein Subfractions to a Less Atherogenic Pattern in Humans
J. Nutr., July 1, 2004; 134(7): 1724 - 1728.
[Abstract] [Full Text]


Home page
Am. J. Clin. Nutr.Home page
H. E Theobald, P. J Chowienczyk, R. Whittall, S. E Humphries, and T. A. Sanders
LDL cholesterol-raising effect of low-dose docosahexaenoic acid in middle-aged men and women
Am. J. Clinical Nutrition, April 1, 2004; 79(4): 558 - 563.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
C. Ko, S. M. O'Rourke, and L.-S. Huang
A fish oil diet produces different degrees of suppression of apoB and triglyceride secretion in human apoB transgenic mouse strains
J. Lipid Res., October 1, 2003; 44(10): 1946 - 1955.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
S. Munoz, M. Merlos, D. Zambon, C. Rodriguez, J. Sabate, E. Ros, and J. C. Laguna
Walnut-enriched diet increases the association of LDL from hypercholesterolemic men with human HepG2 cells
J. Lipid Res., December 1, 2001; 42(12): 2069 - 2076.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. Asset, E. Bauge, J. C. Fruchart, and J. Dallongeville
Lack of Triglyceride-Lowering Properties of Fish Oil in Apolipoprotein E-Deficient Mice
Arterioscler. Thromb. Vasc. Biol., March 1, 2001; 21(3): 401 - 406.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
H.-C. Hsu, Y.-T. Lee, and M.-F. Chen
Effect of n-3 fatty acids on the composition and binding properties of lipoproteins in hypertriglyceridemic patients1
Am. J. Clinical Nutrition, January 1, 2000; 71(1): 28 - 35.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
P. J Nestel
Fish oil and cardiovascular disease: lipids and arterial function
Am. J. Clinical Nutrition, January 1, 2000; 71(1): 228S - 231S.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Wilkinson, J. A. Higgins, C. Fitzsimmons, and D. E. Bowyer
Dietary Fish Oils Modify the Assembly of VLDL and Expression of the LDL Receptor in Rabbit Liver
Arterioscler. Thromb. Vasc. Biol., September 1, 1998; 18(9): 1490 - 1497.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
B. J. M. van Vlijmen, R. P. Mensink, H. B. van 't Hof, R. F. G. Offermans, M. H. Hofker, and L. M. Havekes
Effects of dietary fish oil on serum lipids and VLDL kinetics in hyperlipidemic apolipoprotein E*3-Leiden transgenic mice
J. Lipid Res., June 1, 1998; 39(6): 1181 - 1188.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
W. R. Fisher, L. A. Zech, and P. W. Stacpoole
Apolipoprotein B metabolism in hypertriglyceridemic diabetic patients administered either a fish oil- or vegetable oil-enriched diet
J. Lipid Res., February 1, 1998; 39(2): 388 - 401.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. L. Barbeau, K. F. Klemp, J. R. Guyton, and K. A. Rogers
Dietary Fish Oil : Influence on Lesion Regression in the Porcine Model of Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., April 1, 1997; 17(4): 688 - 694.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 1992 by the American Society for Biochemistry and Molecular Biology.